Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Seth Heldenbrand

TitleAssociate Dean for Experiential Educ
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentExperiential Education, College of Pharmacy
Address6/110C ED II
320 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-686-6392
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Dayer LE, MacCamy KL, Heldenbrand SD, McKeirnan KC, Robinson JD. A Multisite, Longitudinal Study Assessing Prevalence of Anxiety in Student Pharmacists. Am J Pharm Educ. 2024 Nov 16; 88(12):101334. PMID: 39557213.
      View in: PubMed
    2. MacCamy KL, Heldenbrand SD, Robinson JD. A multisite, longitudinal study assessing prevalence of depression in student pharmacists. Am J Pharm Educ. 2024 Feb; 88(2):100634. PMID: 38141954.
      View in: PubMed
    3. Kanmaz TJ, Culhane NS, Berenbrok LA, Jarrett J, Johanson EL, Ruehter VL, Trolli E, Welch LH, Heldenbrand SD. A Curriculum Crosswalk of the Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2020 11; 84(11):8077. PMID: 34283755.
      View in: PubMed
    4. Fuller KA, Heldenbrand SD, Smith MD, Malcom DR. A Paradigm Shift in US Experiential Pharmacy Education Accelerated by the COVID-19 Pandemic. Am J Pharm Educ. 2020 06; 84(6):ajpe8149. PMID: 32665722.
      View in: PubMed
    5. Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. Am J Pharm Educ. 2018 09; 82(7):6326. PMID: 30323388.
      View in: PubMed
    6. Maldonado AQ, West-Thielke P, Dew MA, Peipert JD, Heldenbrand S, Kaiser TE, Chisholm-Burns M, Potter LM. Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation. Clin Transplant. 2018 09; 32(9):e13362. PMID: 30053319.
      View in: PubMed
    7. Pinelli NR, Sease JM, Nola K, Kyle JA, Heldenbrand SD, Penzak SR, Ginsburg DB. The Importance of Authentic Leadership to all Generations Represented within Academic Pharmacy. Am J Pharm Educ. 2018 08; 82(6):6694. PMID: 30181676.
      View in: PubMed
    8. Choi AN, Flowers SK, Heldenbrand SD. Becoming more holistic: A literature review of nonacademic factors in the admissions process of colleges and schools of pharmacy and other health professions. Curr Pharm Teach Learn. 2018 10; 10(10):1429-1437. PMID: 30527373.
      View in: PubMed
    9. Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S. Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points. JMIR Mhealth Uhealth. 2017 Apr 19; 5(4):e45. PMID: 28428169.
      View in: PubMed
    10. Heldenbrand S, Li C, Cross RP, DePiero KA, Dick TB, Ferguson K, Kim M, Newkirk E, Park JM, Sudaria-Kerr J, Tichy EM, Ueda KR, Weng R, Wisniewski J, Gabardi S. Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transpl Infect Dis. 2016 Dec; 18(6):904-912. PMID: 27639246.
      View in: PubMed
    11. Doyle IC, Maldonado AQ, Heldenbrand S, Tichy EM, Trofe-Clark J. Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies. Am J Health Syst Pharm. 2016 Jun 15; 73(12):909-20. PMID: 27189855.
      View in: PubMed
    12. Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc (2003). 2016 May-Jun; 56(3):293-302. PMID: 27067551.
      View in: PubMed
    13. Heldenbrand SD, Flowers SK, Bordelon BJ, Gubbins PO, O'Brien C, Stowe CD, Martin BC. Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum. Am J Pharm Educ. 2016 Mar 25; 80(2):27. PMID: 27073280.
      View in: PubMed
    14. Syal G, Heldenbrand SD, Duarte-Rojo A. Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. Am J Ther. 2016 Mar-Apr; 23(2):e570-1. PMID: 25549078.
      View in: PubMed
    15. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst. J Am Pharm Assoc (2003). 2013 Jul-Aug; 53(4):345. PMID: 23892801.
      View in: PubMed
    16. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013 Mar-Apr; 53(2):172-81. PMID: 23571625.
      View in: PubMed
    17. Gubbins PO, Heldenbrand S. Clinically relevant drug interactions of current antifungal agents. Mycoses. 2010 Mar 01; 53(2):95-113. PMID: 20002883.
      View in: PubMed
    18. Warmack TS, Estes MA, Heldenbrand S, Franks AM. Beta-adrenergic antagonists in hypertension: a review of the evidence. Ann Pharmacother. 2009 Dec; 43(12):2031-43. PMID: 19934392.
      View in: PubMed
    Heldenbrand's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description